The WHO issues its first official guidance on GLP-1 drugs for obesity treatment, as the disease affects over one billion ...

A new study finds a possible association between GLP-1 drugs like semaglutide and chronic cough, though the authors are ...

Okava Pharmaceuticals, a San Francisco based company, plans to introduce on Tuesday a new GLP-1 clinical weight loss study ...

The weight loss medications can be part of a long-term treatment strategy for adults, according to new World Health ...

GLP-1 drugs, which include Ozempic and Wegovy, have become one of the most closely watched experimental approaches for ...

The World Health Organization conditionally recommended GLP-1 drugs for obesity. A physician breaks down what you need to ...

The World Health Organization on Monday released new guidance on GLP-1 medications for adults with obesity, recommending ...

Usage of GLP-1 medications has increased over the past 18 months, with highest adoption among women and adults aged 50-64, ...

A California company, Okava Pharmaceuticals, has launched a clinical trial testing a GLP-1–based weight loss treatment in 50 ...

November 25, 2025 – PRESSADVANTAGE – LifeRx.md announced that it has implemented reduced pricing for its personalized GLP-1 ...

GLP-1 weight loss drugs are now being tested in pets. San Francisco-based Okawa Pharmaceuticals has launched a clinical trial ...

The World Health Organization is now recommending GLP-1 drugs as a tool to manage obesity in adults. The guidance, which says ...